176 related articles for article (PubMed ID: 31062847)
1. Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.
Cui Y; Wen W; Zheng T; Li H; Gao YT; Cai H; You M; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Am J Epidemiol; 2019 Aug; 188(8):1512-1528. PubMed ID: 31062847
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
3. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
[No Abstract] [Full Text] [Related]
4. Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
Baglia ML; Cui Y; Zheng T; Yang G; Li H; You M; Xu L; Murff H; Gao YT; Zheng W; Xiang YB; Shu XO
Cancer Res Treat; 2019 Apr; 51(2):538-546. PubMed ID: 29986576
[TBL] [Abstract][Full Text] [Related]
5. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
7. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
9. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
10. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive medication use and incident breast cancer in women.
Devore EE; Kim S; Ramin CA; Wegrzyn LR; Massa J; Holmes MD; Michels KB; Tamimi RM; Forman JP; Schernhammer ES
Breast Cancer Res Treat; 2015 Feb; 150(1):219-29. PubMed ID: 25701121
[TBL] [Abstract][Full Text] [Related]
12. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
13. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
Lee JM; Park YM; Yun JS; Ahn YB; Lee KM; Kim DB; Lee JM; Han K; Ko SH
PLoS One; 2020; 15(1):e0226351. PubMed ID: 31978054
[TBL] [Abstract][Full Text] [Related]
14. The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
Hsu T; Speers CH; Kennecke HF; Cheung WY
Cancer; 2017 May; 123(10):1839-1847. PubMed ID: 28081292
[TBL] [Abstract][Full Text] [Related]
15. Contribution of income-related inequality and healthcare utilisation to survival in cancers of the lung, liver, stomach and colon.
Yim J; Hwang SS; Yoo KY; Kim CY
J Epidemiol Community Health; 2012 Jan; 66(1):37-40. PubMed ID: 20961877
[TBL] [Abstract][Full Text] [Related]
16. The impact of screening on the survival of colorectal cancer in Shanghai, China: a population based study.
Li X; Zhou Y; Luo Z; Gu Y; Chen Y; Yang C; Wang J; Xiao S; Sun Q; Qian M; Zhao G
BMC Public Health; 2019 Jul; 19(1):1016. PubMed ID: 31357981
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
18. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
19. Medication-Naïve Blood Pressure and Incident Cancers: Analysis of 2 Nationwide Population-Based Databases.
Kaneko H; Yano Y; Lee HH; Lee H; Okada A; Itoh H; Morita K; Fukui A; Fujiu K; Suzuki Y; Matsuoka S; Nakamura S; Michihata N; Jo T; Takeda N; Morita H; Yokoo T; Nishiyama A; Node K; Viera AJ; Muntner P; Oparil S; Kim HC; Yasunaga H; Komuro I
Am J Hypertens; 2022 Aug; 35(8):731-739. PubMed ID: 35512273
[TBL] [Abstract][Full Text] [Related]
20. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
